AIM: To compare presentation, progress, and outcome of acute bacterial meningitis in HIV seropositive and seronegative children. METHODS: A double blind randomised placebo controlled study of the use of dexamethasone as adjuvant therapy in acute bacterial meningitis, in children aged 2 months to 13 years, was carried out from July 1997 to March 2001. A total of 598 children were enrolled, of whom 459 were tested for HIV serostatus. RESULTS: Of the 459 children, 34% were HIV seropositive. Their presentation was similar to HIV seronegative children but more were shocked on arrival at hospital (33/157 v 12/302), and more had a focus of infection (85/157 v 57/302). HIV positive children had a higher incidence of Streptococcus pneumoniae infections (52% v 32%). Sixty four cases relapsed; 67% were in HIV positive patients. The mortality in HIV positive children was 65% compared with 36% in HIV negative children. The number of survivors in each group was similar. Hearing loss was more common in HIV negative than HIV positive children (66.3% v 47.2%). Steroid therapy had no influence on meningitis in HIV positive children, but the mortality in HIV negative children was 61% in children given steroids, and 39% in those who did not receive steroids. CONCLUSION:HIV seropositive children who develop bacterial meningitis have a high mortality and are prone to recurrent disease. There is an urgent need to prevent both primary and recurrent infections.
RCT Entities:
AIM: To compare presentation, progress, and outcome of acute bacterial meningitis in HIV seropositive and seronegative children. METHODS: A double blind randomised placebo controlled study of the use of dexamethasone as adjuvant therapy in acute bacterial meningitis, in children aged 2 months to 13 years, was carried out from July 1997 to March 2001. A total of 598 children were enrolled, of whom 459 were tested for HIV serostatus. RESULTS: Of the 459 children, 34% were HIV seropositive. Their presentation was similar to HIV seronegative children but more were shocked on arrival at hospital (33/157 v 12/302), and more had a focus of infection (85/157 v 57/302). HIV positive children had a higher incidence of Streptococcus pneumoniae infections (52% v 32%). Sixty four cases relapsed; 67% were in HIV positive patients. The mortality in HIV positive children was 65% compared with 36% in HIV negative children. The number of survivors in each group was similar. Hearing loss was more common in HIV negative than HIV positive children (66.3% v 47.2%). Steroid therapy had no influence on meningitis in HIV positive children, but the mortality in HIV negative children was 61% in children given steroids, and 39% in those who did not receive steroids. CONCLUSION: HIV seropositive children who develop bacterial meningitis have a high mortality and are prone to recurrent disease. There is an urgent need to prevent both primary and recurrent infections.
Authors: Yared Mekonnen; Nicole H Dukers; Eduard Sanders; Wendelien Dorigo; Dawit Wolday; Ab Schaap; Ronald B Geskus; Roel A Coutinho; Arnaud Fontanet Journal: AIDS Date: 2003-04-11 Impact factor: 4.177
Authors: George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129
Authors: Job Cj Calis; Kamija S Phiri; E Brian Faragher; Bernard J Brabin; Imelda Bates; Luis E Cuevas; Rob J de Haan; Ajib I Phiri; Pelani Malange; Mirriam Khoka; Paul Jm Hulshof; Lisette van Lieshout; Marcel Ghm Beld; Yik Y Teo; Kirk A Rockett; Anna Richardson; Dominic P Kwiatkowski; Malcolm E Molyneux; Michaël Boele van Hensbroek Journal: Malawi Med J Date: 2016-09 Impact factor: 0.875
Authors: Enitan D Carrol; Malcolm Guiver; Standwell Nkhoma; Limangeni A Mankhambo; John Marsh; Paul Balmer; Daniel L Banda; Graham Jeffers; Sarah A White; Elizabeth M Molyneux; Malcolm E Molyneux; Rosalind L Smyth; C Anthony Hart Journal: Pediatr Infect Dis J Date: 2007-05 Impact factor: 2.129
Authors: Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke Journal: MMWR Recomm Rep Date: 2009-09-04
Authors: K S Phiri; J C J Calis; D Kachala; E Borgstein; J Waluza; I Bates; B Brabin; M Boele van Hensbroek Journal: J Clin Pathol Date: 2009-08 Impact factor: 3.411
Authors: Femkje A M Jonker; Job C J Calis; Michael Boele van Hensbroek; Kamija Phiri; Ronald B Geskus; Bernard J Brabin; Tjalling Leenstra Journal: PLoS One Date: 2012-08-16 Impact factor: 3.240